A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation
about
Protection from doxorubicin-induced cardiomyopathy using the modified anthracycline N-benzyladriamycin-14-valerate (AD 198).Platelet activating factor: the good and the bad in the ischemic/reperfused heart.Platelet activating factor in heart failure: potential role in disease progression and novel target for therapy.Protein S-nitrosylation in preconditioning and postconditioning.Catestatin reduces myocardial ischaemia/reperfusion injury: involvement of PI3K/Akt, PKCs, mitochondrial KATP channels and ROS signalling.
P2860
A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A cardioprotective role for pl ...... NOS-dependent S-nitrosylation
@en
A cardioprotective role for pl ...... NOS-dependent S-nitrosylation.
@nl
type
label
A cardioprotective role for pl ...... NOS-dependent S-nitrosylation
@en
A cardioprotective role for pl ...... NOS-dependent S-nitrosylation.
@nl
prefLabel
A cardioprotective role for pl ...... NOS-dependent S-nitrosylation
@en
A cardioprotective role for pl ...... NOS-dependent S-nitrosylation.
@nl
P2093
P2860
P1476
A cardioprotective role for pl ...... NOS-dependent S-nitrosylation
@en
P2093
Elaine I Tuomanen
Peter J Leary
Polly A Hofmann
R Ray Morrison
Surender Rajasekaran
Thomas K Chin
P2860
P304
P356
10.1152/AJPHEART.00269.2008
P577
2008-04-25T00:00:00Z